169 related articles for article (PubMed ID: 15611843)
21. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor.
Menges CW; McCance DJ
Oncogene; 2008 May; 27(20):2934-40. PubMed ID: 18059341
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
[TBL] [Abstract][Full Text] [Related]
24. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
Davidson SM; Hausenloy D; Duchen MR; Yellon DM
Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
[TBL] [Abstract][Full Text] [Related]
25. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
[TBL] [Abstract][Full Text] [Related]
26. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
[TBL] [Abstract][Full Text] [Related]
28. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.
Chan CY; Chen YS; Lee HH; Huang HS; Lai YL; Chen CF; Ma MC
Life Sci; 2007 Aug; 81(9):717-23. PubMed ID: 17707437
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin protects the systolic function of neonatal hearts against ischaemia/reperfusion injury.
Vilarinho KA; de Oliveira PP; Saad MJ; Eghtesady P; Filho LM; Vieira RW; Petrucci O
Eur J Cardiothorac Surg; 2013 Jan; 43(1):156-62. PubMed ID: 22564802
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.
Lu MJ; Chen YS; Huang HS; Ma MC
Life Sci; 2012 May; 90(19-20):776-84. PubMed ID: 22521289
[TBL] [Abstract][Full Text] [Related]
32. [Anti-apoptotic effect of insulin in myocardial ischemia-reperfusion and its principal signaling pathway].
Gao F; Yan WL; Zhang HF; Shi DW; Mo QZ; Ma XL
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):153-6. PubMed ID: 12816694
[TBL] [Abstract][Full Text] [Related]
33. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels.
Shi Y; Rafiee P; Su J; Pritchard KA; Tweddell JS; Baker JE
Basic Res Cardiol; 2004 May; 99(3):173-82. PubMed ID: 15088102
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation.
Kretz A; Happold CJ; Marticke JK; Isenmann S
Mol Cell Neurosci; 2005 Aug; 29(4):569-79. PubMed ID: 15936213
[TBL] [Abstract][Full Text] [Related]
35. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.
Brar BK; Stephanou A; Knight R; Latchman DS
J Mol Cell Cardiol; 2002 Apr; 34(4):483-92. PubMed ID: 11991736
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.
Jun JH; Jun NH; Shim JK; Shin EJ; Kwak YL
Eur J Pharmacol; 2014 Dec; 745():1-9. PubMed ID: 25446919
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling.
Efthymiou CA; Mocanu MM; Yellon DM
J Cardiovasc Pharmacol; 2005 Mar; 45(3):247-52. PubMed ID: 15725950
[TBL] [Abstract][Full Text] [Related]
38. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.
Kilic E; Kilic U; Soliz J; Bassetti CL; Gassmann M; Hermann DM
FASEB J; 2005 Dec; 19(14):2026-8. PubMed ID: 16207820
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.
van der Meer P; Lipsic E; Henning RH; de Boer RA; Suurmeijer AJ; van Veldhuisen DJ; van Gilst WH
Eur J Heart Fail; 2004 Dec; 6(7):853-9. PubMed ID: 15556046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
